Načítá se...
Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure
Ventricular arrhythmias (VA) are of major concern in the field of cell therapy, potentially limiting its safety and efficacy. We sought to investigate the effects of CD34(+) cell therapy on VA burden in patients with chronic heart failure (CHF). We performed registry data analysis of patients with C...
Uloženo v:
| Vydáno v: | Cell Transplant |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6719496/ https://ncbi.nlm.nih.gov/pubmed/31046425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0963689719840351 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|